New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment

Int Rev Immunol. 2011 Aug;30(4):219-31. doi: 10.3109/08830185.2011.602443.

Abstract

Celiac disease (CD) is an immune-mediated enteropathy triggered by the ingestion of gluten in genetically susceptible individuals. It is one of the most common lifelong disorders on a worldwide basis. Celiac enteropathy is the final consequence of an abnormal immune reaction, showing features of both an innate and an adaptive response to gluten prolamins. The clinical spectrum is wide, including cases with either typical intestinal or atypical extraintestinal features, and silent forms. The only available treatment consists in dietary exclusion of grains containing gluten. New pharmacological treatment are currently under scrutiny.

Publication types

  • Review

MeSH terms

  • Adaptive Immunity
  • Africa, Northern / epidemiology
  • Animals
  • Arabs*
  • Celiac Disease / diet therapy
  • Celiac Disease / epidemiology
  • Celiac Disease / immunology*
  • Celiac Disease / physiopathology
  • Europe / ethnology
  • European Continental Ancestry Group*
  • Glutens / immunology
  • Humans
  • Hyperplasia
  • Immunity, Innate
  • Intestines / pathology*
  • Prevalence
  • United States / epidemiology

Substances

  • Glutens